3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
37
Melanoma
17
Prostatic Neoplasms
16
Lung Neoplasms
14
Neoplasms
13
Squamous Cell Carcinoma of Head and Neck
10
Neoplasm Metastasis
9
Carcinoma, Non-Small-Cell Lung
9
Precancerous Conditions
8
Lymphoma
8
Uterine Cervical Neoplasms
6
Pancreatic Neoplasms
6
Leukemia
6
Esophageal Neoplasms
6
Colorectal Neoplasms
6
Colonic Neoplasms
6
Breast Neoplasms, Male
6
Urinary Bladder Neoplasms
5
Rectal Neoplasms
5
Myelodysplastic Syndromes
5
Lymphoma, Follicular
5
Leukemia, Myeloid, Acute
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Head and Neck Neoplasms
5
Barrett Esophagus
5
Adenocarcinoma Of Esophagus
5
Salivary Gland Neoplasms
4
Recurrence
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Interventions
enzalutamide
9
Abiraterone Acetate
5
rucaparib
2
Prednisone
2
Docetaxel
2
pembrolizumab
1
fluzoparib
1
apatinib
1
abiraterone
1
Blood Specimen Collection
1
Biopsy
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Metastatic Castration Resistant Prostate Cancer
×
Biopsy
×
Clear all
NCT02424448
2016-07-26
BIOMETHS
The Christie NHS Foundation Trust
Completed
6 enrolled